Pathstone Holdings
MRVI icon

Pathstone Holdings’s Maravai LifeSciences MRVI Stock Holding History

Pathstone Holdings’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-18,608
Closed -$41.1K – 2276
2025
Q1 		$41.1K Buy
18,608
+8,343
+81% +$33K ﹤0.01% 2185
2024
Q4 		$55.9K Sell
10,265
-1,803
-15% -$11.6K ﹤0.01% 2259
2024
Q3 		$100K Buy
+12,068
New +$104K ﹤0.01% 2237
2024
Q2 		– Sell
-10,132
Closed -$87.8K – 2356
2024
Q1 		$87.8K Buy
+10,132
New +$68.5K ﹤0.01% 2231

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.03B AUM 19.83% 1-Year Est. Return
PD
Point72 (DIFC) Dubai, United Arab Emirates $1.44B AUM 15.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return